Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Buy
59
DRUG Quote, Financials, Valuation and Earnings
Last price:
$32.58
Seasonality move
:
8.15%
Day range:
$32.04 - $33.65
52-week range:
$0.93 - $79.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.68x
Volume:
23.7K
Avg. volume:
28.6K
1-year change:
2840.27%
Market cap:
$228.9M
Revenue:
--
EPS (TTM):
-$0.18
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $264K | $5M | $9.5M | $3.7M | $867.2K | |
| Selling, General & Admin | $85.2K | $1.8M | $2M | $1.6M | $1.1M | |
| Other Inc / (Exp) | -- | $121.9K | $8K | $10.5K | -$6.8K | |
| Operating Expenses | $353.2K | $6.9M | $11.7M | $5.5M | $2.1M | |
| Operating Income | -$353.2K | -$6.9M | -$11.7M | -$5.5M | -$2.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$357.4K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$357.4K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$357.4K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Basic EPS (Cont. Ops) | -$0.28 | -$3.81 | -$4.74 | -$1.47 | -$0.48 | |
| Diluted EPS (Cont. Ops) | -$0.28 | -$3.81 | -$4.74 | -$1.47 | -$0.48 | |
| Weighted Average Basic Share | $1.3M | $1.8M | $2.5M | $3.7M | $4.3M | |
| Weighted Average Diluted Share | $1.3M | $1.8M | $2.5M | $3.7M | $4.3M | |
| EBITDA | -$353.2K | -$6.9M | -$11.7M | -$5.4M | -$2M | |
| EBIT | -$353.2K | -$6.9M | -$11.7M | -$5.5M | -$2.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$353.2K | -$6.9M | -$11.7M | -$5.5M | -$2.1M | |
| Operating Income (Adjusted) | -$353.2K | -$6.9M | -$11.7M | -$5.5M | -$2.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $270.7K | $3.1M | $1.1M | $900.2K | $744.7K | |
| Selling, General & Admin | $161.6K | $695.3K | $587.3K | $294.7K | $385.3K | |
| Other Inc / (Exp) | -$25K | -$27K | -$27.3K | $10.8K | $1.2M | |
| Operating Expenses | $473.6K | $3.8M | $1.7M | $1.2M | $1.2M | |
| Operating Income | -$473.6K | -$3.8M | -$1.7M | -$1.2M | -$1.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$519.5K | -$3.9M | -$1.7M | -$1.2M | $35.3K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$511.8K | -$3.9M | -$1.7M | -$1.2M | $35.3K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$519.5K | -$3.9M | -$1.7M | -$1.2M | $35.3K | |
| Basic EPS (Cont. Ops) | -$0.41 | -$1.63 | -$0.48 | -$0.32 | $0.01 | |
| Diluted EPS (Cont. Ops) | -$0.41 | -$1.63 | -$0.48 | -$0.32 | $0.01 | |
| Weighted Average Basic Share | $1.3M | $2.4M | $3.6M | $3.8M | $6.2M | |
| Weighted Average Diluted Share | $1.3M | $2.4M | $3.6M | $3.8M | $6.6M | |
| EBITDA | -$473.6K | -$3.8M | -$1.7M | -$1.2M | -$1.1M | |
| EBIT | -$473.6K | -$3.8M | -$1.7M | -$1.2M | -$1.2M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$473.6K | -$3.8M | -$1.7M | -$1.2M | -$1.2M | |
| Operating Income (Adjusted) | -$473.6K | -$3.8M | -$1.7M | -$1.2M | -$1.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $512.7K | $7.8M | $7.6M | $3.5M | $713.5K | |
| Selling, General & Admin | $247K | $2.4M | $1.9M | $1.3M | $1.1M | |
| Other Inc / (Exp) | -$25K | $123.7K | $6.4K | $49.1K | $1.2M | |
| Operating Expenses | $805.1K | $10.4M | $9.6M | $5M | $2M | |
| Operating Income | -$805.1K | -$10.4M | -$9.6M | -$5M | -$2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$855.2K | -$10.3M | -$9.6M | -$5M | -$789.1K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$845.4K | -$10.2M | -$9.6M | -$5M | -$786.6K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$855.2K | -$10.3M | -$9.6M | -$5M | -$789.1K | |
| Basic EPS (Cont. Ops) | -$0.67 | -$4.76 | -$3.63 | -$1.31 | -$0.18 | |
| Diluted EPS (Cont. Ops) | -$0.67 | -$4.76 | -$3.63 | -$1.31 | -$0.18 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$805.1K | -$10.4M | -$9.6M | -$5M | -$1.9M | |
| EBIT | -$805.1K | -$10.4M | -$9.6M | -$5M | -$2M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$805.1K | -$10.4M | -$9.6M | -$5M | -$2M | |
| Operating Income (Adjusted) | -$805.1K | -$10.4M | -$9.6M | -$5M | -$2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $270.7K | $3.1M | $1.1M | $900.2K | $744.7K | |
| Selling, General & Admin | $161.6K | $695.3K | $587.3K | $294.7K | $385.3K | |
| Other Inc / (Exp) | -$25K | -$27K | -$27.3K | $10.8K | $1.2M | |
| Operating Expenses | $473.6K | $3.8M | $1.7M | $1.2M | $1.2M | |
| Operating Income | -$473.6K | -$3.8M | -$1.7M | -$1.2M | -$1.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$519.5K | -$3.9M | -$1.7M | -$1.2M | $35.3K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$511.8K | -$3.9M | -$1.7M | -$1.2M | $35.3K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$519.5K | -$3.9M | -$1.7M | -$1.2M | $35.3K | |
| Basic EPS (Cont. Ops) | -$0.41 | -$1.63 | -$0.48 | -$0.32 | $0.01 | |
| Diluted EPS (Cont. Ops) | -$0.41 | -$1.63 | -$0.48 | -$0.32 | $0.01 | |
| Weighted Average Basic Share | $1.3M | $2.4M | $3.6M | $3.8M | $6.2M | |
| Weighted Average Diluted Share | $1.3M | $2.4M | $3.6M | $3.8M | $6.6M | |
| EBITDA | -$473.6K | -$3.8M | -$1.7M | -$1.2M | -$1.1M | |
| EBIT | -$473.6K | -$3.8M | -$1.7M | -$1.2M | -$1.2M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$473.6K | -$3.8M | -$1.7M | -$1.2M | -$1.2M | |
| Operating Income (Adjusted) | -$473.6K | -$3.8M | -$1.7M | -$1.2M | -$1.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $597.6K | $15.5M | $8.5M | $5M | $4.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $58.5K | $131.9K | $120.2K | $20.4K | $160.3K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $656.1K | $15.7M | $8.7M | $5M | $4.4M | |
| Property Plant And Equipment | -- | -- | $101.5K | $48.9K | $87.1K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $657.6K | $15.7M | $8.8M | $5.1M | $4.5M | |
| Accounts Payable | $103.4K | $467.7K | $911.4K | $134.1K | $301.7K | |
| Accrued Expenses | $9.3K | $32.9K | $115.7K | $18.4K | $30.9K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $49.7K | $54.1K | $58.8K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $112.8K | $500.6K | $1.1M | $206.6K | $391.3K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $112.8K | $500.6K | $1.1M | $206.6K | $420.6K | |
| Common Stock | $732.6K | $21.2M | $23.6M | $24.9M | $26.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $544.8K | $15.2M | $7.7M | $4.9M | $4.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $544.8K | $15.2M | $7.7M | $4.9M | $4.1M | |
| Total Liabilities and Equity | $657.6K | $15.7M | $8.8M | $5.1M | $4.5M | |
| Cash and Short Terms | $597.6K | $15.5M | $8.5M | $5M | $4.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6M | $11.9M | $8.3M | $5.1M | $40.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $91.9K | $111.5K | $116.5K | $24.2K | $179.7K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.7M | $12.1M | $8.4M | $5.2M | $40.6M | |
| Property Plant And Equipment | -- | -- | $89K | $36.4K | $123.3K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.7M | $12.1M | $8.5M | $5.2M | $40.7M | |
| Accounts Payable | $74.8K | $378.5K | $237.4K | $602.7K | $260.3K | |
| Accrued Expenses | -- | $5.5K | $100.2K | -- | $10.6K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $51.5K | $41.1K | $50.6K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $74.8K | $384K | $389.1K | $643.9K | $321.6K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $74.8K | $384K | $429.3K | $643.9K | $398.3K | |
| Common Stock | $2.4M | $21.3M | $24.8M | $26.4M | $62M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.6M | $11.7M | $8.1M | $4.5M | $40.3M | |
| Total Liabilities and Equity | $1.7M | $12.1M | $8.5M | $5.2M | $40.7M | |
| Cash and Short Terms | $1.6M | $11.9M | $8.3M | $5.1M | $40.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$357.4K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Depreciation & Amoritzation | -- | -- | $4.7K | $53.7K | $53.9K | |
| Stock-Based Compensation | $120K | $696.5K | $685K | $853.7K | $617.1K | |
| Change in Accounts Receivable | -- | -$87.1K | -$35.7K | $88K | -$9.7K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$214.6K | -$5.8M | -$10.6M | -$5.2M | -$1.4M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$5.6K | -$63.8K | -$65.9K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$1.4M | -$626.2K | -$20K | -- | |
| Cash From Financing | $750.2K | $20.6M | $4.1M | $1.6M | $595.7K | |
| Beginning Cash (CF) | $59.5K | $632.7K | $15.5M | $8.6M | $5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $535.6K | $14.8M | -$6.6M | -$3.6M | -$764K | |
| Ending Cash (CF) | $595.1K | $15.6M | $9.1M | $5M | $4.2M | |
| Levered Free Cash Flow | -$214.6K | -$5.8M | -$10.6M | -$5.2M | -$1.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$511.8K | -$3.9M | -$1.7M | -$1.2M | $35.3K | |
| Depreciation & Amoritzation | -- | -- | $13.3K | $13.3K | $15.3K | |
| Stock-Based Compensation | $90.6K | $207K | $356.4K | $160.8K | $125.7K | |
| Change in Accounts Receivable | -$380 | -$31.4K | $71.1K | -$5.9K | -$12K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$421.7K | -$3.9M | -$2M | -$603.9K | -$1.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$17.6K | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$15.8K | -$16.1K | -$17K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $17.6K | -- | -$19.9K | -- | -$59.6K | |
| Cash From Financing | $1.5M | $93.8K | $1.7M | $645K | $37.1M | |
| Beginning Cash (CF) | $613.8K | $15.7M | $8.6M | $5M | $4.1M | |
| Foreign Exchange Rate Adjustment | -$11.6K | $151.8K | -$5.2K | -$31.1K | $1.2M | |
| Additions / Reductions | $1M | -$3.8M | -$301.4K | $41.1K | $36M | |
| Ending Cash (CF) | $1.6M | $12M | $8.3M | $5M | $41.2M | |
| Levered Free Cash Flow | -$421.7K | -$3.9M | -$2M | -$603.9K | -$1.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$845.4K | -$10.2M | -$9.6M | -$5M | -$786.6K | |
| Depreciation & Amoritzation | -- | -- | $18.1K | $53.7K | $55.9K | |
| Stock-Based Compensation | $210.6K | $813K | $834.4K | $658.1K | $582K | |
| Change in Accounts Receivable | -- | -$118.1K | $66.7K | $11.1K | -$15.8K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$591K | -$9.3M | -$8.7M | -$3.8M | -$1.8M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$21.4K | -$64.1K | -$66.8K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$646K | -- | -- | |
| Cash From Financing | $2.2M | $19.2M | $5.6M | $607.8K | $37M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.6M | $10M | -$3M | -$3.2M | $35.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$591K | -$9.3M | -$8.7M | -$3.8M | -$1.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$511.8K | -$3.9M | -$1.7M | -$1.2M | $35.3K | |
| Depreciation & Amoritzation | -- | -- | $13.3K | $13.3K | $15.3K | |
| Stock-Based Compensation | $90.6K | $207K | $356.4K | $160.8K | $125.7K | |
| Change in Accounts Receivable | -$380 | -$31.4K | $71.1K | -$5.9K | -$12K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$421.7K | -$3.9M | -$2M | -$603.9K | -$1.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$17.6K | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$15.8K | -$16.1K | -$17K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $17.6K | -- | -$19.9K | -- | -$59.6K | |
| Cash From Financing | $1.5M | $93.8K | $1.7M | $645K | $37.1M | |
| Beginning Cash (CF) | $613.8K | $15.7M | $8.6M | $5M | $4.1M | |
| Foreign Exchange Rate Adjustment | -$11.6K | $151.8K | -$5.2K | -$31.1K | $1.2M | |
| Additions / Reductions | $1M | -$3.8M | -$301.4K | $41.1K | $36M | |
| Ending Cash (CF) | $1.6M | $12M | $8.3M | $5M | $41.2M | |
| Levered Free Cash Flow | -$421.7K | -$3.9M | -$2M | -$603.9K | -$1.1M | |
Get DRUG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DRUG
Sector
P/E ratio
--
23.51x
PEG ratio
--
0.00x
P/B ratio
5.68x
1.65x
Price / LTM sales
--
1.60x
Growth Metrics
DRUG
Sector
Revenue growth
--
4.92%
Earnings growth
--
7.49%
Revenue (5-year growth)
--
8.25%
Earnings forecast
-$0.33
-$0.20
Profitability
DRUG
Sector
Profitability FY 2025
--
$53.7M
Return on invested capital
--
-14.69%
Return on assets
--
-11.84%
Return on equity
--
-17.27%
Earnings Date
Last Earnings Date
Feb
13
Next Earnings Date
May
15
Estimated Next Earnings Date
May
15
Balance Sheet
DRUG
Sector
Total cash
$40.3M
$40.3M
Short term investments
--
$34.6M
Total assets
$4.5M
$119.9M
Long term debt
--
$9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is a Millionaire-Maker Stock?
From time to time, investors will run across the term…
5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
